Scorecard › UBER
UBER analyst scorecard · Uber
82 rating actions on UBER in the last 12 months. Of 109 price targets that resolved, 28 were reached while they stood, 73 were replaced by the same firm first, and 8 fell short at their deadline. Ratings: 95% Buy-type, 5% Hold-type, 0% Sell-type. Consensus target $101, 54% above the last close.
Checked through 2026-10-29 · last close $65.52 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
25.7% 28 of 109
Replaced before the deadline
67.0%
Short at the deadline
7.3%
Ratings vs XLK
3 of 28
Buy / Hold / Sell, 12 mo
95 / 5 / 0%
Consensus target
$101 +53.9%
What the Holds say: 2 Hold-type ratings on UBER in the last 12 months carried a median target -1% from the price on the day; 100% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| DA Davidson | Buy | 2026-08-06 | $100 | 2 | 5 | 7 | 0 of 1 |
| BTIG | Buy | 2026-10-07 | $100 | — | — | 0 | — |
| Guggenheim | Buy | 2026-10-16 | $125 | 0 | 3 | 3 | 0 of 1 |
| Wells Fargo | Overweight | 2026-10-05 | $92 | 0 | 15 | 15 | 0 of 1 |
| Cantor Fitzgerald | Overweight | 2026-10-12 | $90 | 3 | 5 | 8 | 1 of 1 |
| Needham | Buy | 2026-08-06 | $109 | 0 | 8 | 9 | 0 of 1 |
| Scotiabank | Sector Outperform | 2026-09-09 | $100 | — | — | 0 | — |
| Susquehanna | Positive | 2026-08-06 | $90 | 0 | 1 | 1 | 0 of 1 |
| Bank of America | Buy | 2026-07-28 | $103 | 1 | 0 | 2 | 0 of 1 |
| Tigress Financial | Buy | 2026-06-12 | $115 | 0 | 1 | 2 | 0 of 1 |
| Bernstein | Outperform | 2026-08-06 | $95 | 0 | 2 | 2 | 0 of 1 |
| Barclays | Overweight | 2026-08-06 | $106 | 1 | 2 | 3 | 0 of 1 |
| KeyBanc | Overweight | 2026-07-14 | $105 | 2 | 2 | 4 | 0 of 1 |
| TD Cowen | Buy | 2026-07-17 | $118 | 1 | 1 | 2 | 0 of 1 |
| Citizens | Market Outperform | 2026-10-07 | $100 | — | — | 0 | — |
| Wedbush | Outperform | 2026-09-08 | $91 | 1 | 0 | 1 | — |
| Rosenblatt | Buy | 2026-09-03 | $100 | — | — | 0 | — |
| JPMorgan | Overweight | 2026-05-07 | $110 | 2 | 4 | 6 | 0 of 1 |
| Truist Securities | Buy | 2026-05-07 | $112 | 1 | 2 | 3 | 0 of 1 |
| UBS | Buy | 2026-05-01 | $110 | 0 | 6 | 6 | 0 of 1 |
| Morgan Stanley | Overweight | 2026-02-05 | $100 | 0 | 2 | 2 | — |
| StoneX | Hold | 2026-09-08 | — | — | — | 0 | — |
| Roth Capital | Buy | 2026-08-10 | $100 | 0 | 0 | 1 | 0 of 1 |
| Jefferies | Buy | 2026-08-10 | $110 | — | — | 0 | — |
| Piper Sandler | Overweight | 2026-05-07 | $105 | 2 | 2 | 4 | 0 of 1 |
| Citigroup | Buy | 2026-02-06 | $110 | 0 | 2 | 2 | 0 of 1 |
| RBC Capital | Outperform | 2026-02-05 | $105 | 4 | 0 | 4 | 0 of 1 |
| Benchmark | Hold | 2026-02-05 | — | — | — | 0 | — |
| Mizuho | Outperform | 2026-02-05 | $110 | 0 | 1 | 1 | 0 of 1 |
| Stifel | Buy | 2026-01-27 | $105 | 0 | 3 | 3 | 0 of 1 |
| Wolfe Research | Outperform | 2026-01-06 | $110 | 1 | 0 | 1 | 1 of 1 |
| Arete Research | Buy | 2025-12-03 | $125 | — | — | 0 | — |
| BMO Capital | Outperform | 2025-11-05 | $106 | 0 | 1 | 1 | 0 of 1 |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor UBER carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Guggenheim | Buy | reiterated | $70.35 | $125 | running to 2027-10-16 | -0.9% |
| 2026-10-12 | Cantor Fitzgerald | Overweight | reiterated | $71.50 | $90 | running to 2027-10-12 | -0.2% |
| 2026-10-07 | Citizens | Market Outperform | reiterated | $68.45 | $100 | running to 2027-10-07 | -9.7% |
| 2026-10-07 | BTIG | Buy | reiterated | $68.45 | $100 | running to 2027-10-07 | -9.7% |
| 2026-10-05 | Wells Fargo | Overweight | maintained | $69.48 | $92 | running to 2027-10-05 | -8.3% |
| 2026-09-09 | Scotiabank | Sector Outperform | initiated | $71.08 | $100 | running to 2027-09-09 | -8.9% |
| 2026-09-08 | Wedbush | Outperform | reiterated | $73.13 | $91 | running to 2027-09-08 | -2.5% |
| 2026-09-08 | StoneX | Hold | reiterated | $73.13 | — | no target | -2.5% |
| 2026-09-03 | Rosenblatt | Buy | maintained | $75.96 | $100 | running to 2027-09-03 | +5.5% |
| 2026-09-03 | BTIG | Buy | reiterated | $75.96 | $100 | running to 2027-09-03 | +5.5% |
| 2026-09-01 | Rosenblatt | Buy | initiated | $75.24 | $100 | running to 2027-09-01 | +6.9% |
| 2026-08-25 | Citizens | Market Outperform | reiterated | $80.35 | $100 | running to 2027-08-25 | +21.9% |
| 2026-08-10 | Roth Capital | Buy | maintained | $78.03 | $100 | running to 2027-08-10 | +4.7% |
| 2026-08-10 | Jefferies | Buy | maintained | $78.03 | $110 | running to 2027-08-10 | +4.7% |
| 2026-08-06 | DA Davidson | Buy | maintained | $70.47 | $100 | running to 2027-08-06 | -5.2% |
| 2026-08-06 | Wells Fargo | Overweight | maintained | $70.47 | $89 | replaced 2026-10-05, new $92 | -5.2% |
| 2026-08-06 | Bernstein | Outperform | maintained | $70.47 | $95 | running to 2027-08-06 | -5.2% |
| 2026-08-06 | Barclays | Overweight | maintained | $70.47 | $106 | running to 2027-08-06 | -5.2% |
| 2026-08-06 | Guggenheim | Buy | reiterated | $70.47 | $125 | running to 2027-08-06 | -5.2% |
| 2026-08-06 | Susquehanna | Positive | maintained | $70.47 | $90 | running to 2027-08-06 | -5.2% |
| 2026-08-06 | Cantor Fitzgerald | Overweight | maintained | $70.47 | $90 | running to 2027-08-06 | -5.2% |
| 2026-08-06 | Needham | Buy | reiterated | $70.47 | $109 | running to 2027-08-06 | -5.2% |
| 2026-07-28 | Bank of America | Buy | maintained | $70.74 | $103 | running to 2027-07-28 | -7.2% |
| 2026-07-17 | TD Cowen | Buy | reiterated | $72.46 | $118 | running to 2027-07-17 | +2.2% |
| 2026-07-16 | BTIG | Buy | reiterated | $74.04 | $100 | running to 2027-07-16 | +1.1% |
| 2026-07-14 | BTIG | Buy | maintained | $72.08 | $100 | running to 2027-07-14 | +4.7% |
| 2026-07-14 | KeyBanc | Overweight | maintained | $72.08 | $105 | running to 2027-07-14 | +4.7% |
| 2026-07-06 | Wells Fargo | Overweight | maintained | $72.42 | $100 | replaced 2026-08-06, new $89 | +2.4% |
| 2026-06-26 | BTIG | Buy | reiterated | $76.20 | $100 | running to 2027-06-26 | +7.7% |
| 2026-06-12 | Tigress Financial | Buy | maintained | $68.85 | $115 | running to 2027-06-12 | -7.8% |
| 2026-05-28 | BTIG | Buy | reiterated | $70.92 | $100 | running to 2027-05-28 | -4.3% |
| 2026-05-26 | DA Davidson | Buy | maintained | $70.12 | $107 | replaced 2026-08-06, new $100 | -6.1% |
| 2026-05-07 | JPMorgan | Overweight | maintained | $76.73 | $110 | running to 2027-05-07 | +7.0% |
| 2026-05-07 | TD Cowen | Buy | maintained | $76.73 | $118 | running to 2027-05-07 | +7.0% |
| 2026-05-07 | Truist Securities | Buy | maintained | $76.73 | $112 | running to 2027-05-07 | +7.0% |
| 2026-05-07 | Wells Fargo | Overweight | maintained | $76.73 | $102 | replaced 2026-07-06, new $100 | +7.0% |
| 2026-05-07 | Piper Sandler | Overweight | maintained | $76.73 | $105 | running to 2027-05-07 | +7.0% |
| 2026-05-07 | Needham | Buy | reiterated | $76.73 | $109 | running to 2027-05-07 | +7.0% |
| 2026-05-06 | DA Davidson | Buy | maintained | $79.17 | $107 | replaced 2026-08-06, new $100 | +9.7% |
| 2026-05-01 | UBS | Buy | maintained | $75.12 | $110 | running to 2027-05-01 | +4.8% |
| 2026-04-28 | Citizens | Market Outperform | reiterated | $74.11 | $100 | running to 2027-04-28 | +7.1% |
| 2026-04-27 | Guggenheim | Buy | reiterated | $76.27 | $125 | running to 2027-04-27 | +10.2% |
| 2026-03-30 | Wells Fargo | Overweight | maintained | $69.91 | $95 | replaced 2026-05-07, new $102 | -7.3% |
| 2026-03-17 | BTIG | Buy | reiterated | $77.79 | $100 | running to 2027-03-17 | +11.1% |
| 2026-03-04 | BTIG | Buy | reiterated | $76.65 | $100 | running to 2027-03-04 | -5.2% |
| 2026-02-23 | DA Davidson | Buy | maintained | $70.72 | $105 | replaced 2026-05-06, new $107 | -14.1% |
| 2026-02-18 | Guggenheim | Buy | maintained | $72.77 | $125 | running to 2027-02-18 | -14.2% |
| 2026-02-06 | Citigroup | Buy | maintained | $74.77 | $110 | running to 2027-02-06 | -13.2% |
| 2026-02-05 | JPMorgan | Overweight | maintained | $75.21 | $105 | replaced 2026-05-07, new $110 | -12.1% |
| 2026-02-05 | RBC Capital | Outperform | reiterated | $75.21 | $105 | running to 2027-02-05 | -12.1% |
| 2026-02-05 | Wells Fargo | Overweight | maintained | $75.21 | $100 | replaced 2026-03-30, new $95 | -12.1% |
| 2026-02-05 | Cantor Fitzgerald | Overweight | maintained | $75.21 | $92 | replaced 2026-08-06, new $90 | -12.1% |
| 2026-02-05 | Morgan Stanley | Overweight | maintained | $75.21 | $100 | running to 2027-08-05 | -12.1% |
| 2026-02-05 | Citizens | Market Perform → Market Outperform | upgrade | $75.21 | $100 | running to 2027-02-05 | -12.1% |
| 2026-02-05 | Benchmark | Hold | reiterated | $75.21 | — | no target | -12.1% |
| 2026-02-05 | Wedbush | Neutral | maintained | $75.21 | $75 | within 5% of price when set | -12.1% |
| 2026-02-05 | Mizuho | Outperform | maintained | $75.21 | $110 | running to 2027-02-05 | -12.1% |
| 2026-02-05 | Needham | Buy | reiterated | $75.21 | $109 | running to 2027-02-05 | -12.1% |
| 2026-02-04 | BTIG | Buy | reiterated | $73.92 | $100 | running to 2027-02-04 | -8.4% |
| 2026-02-03 | Needham | Buy | reiterated | $77.93 | $109 | running to 2027-02-03 | -6.0% |
| 2026-01-27 | Stifel | Buy | maintained | $81.24 | $105 | running to 2027-01-27 | -0.0% |
| 2026-01-22 | Guggenheim | Buy | reiterated | $82.56 | $135 | replaced 2026-02-18, new $125 | +2.0% |
| 2026-01-20 | KeyBanc | Overweight | maintained | $83.72 | $105 | running to 2027-01-20 | +5.6% |
| 2026-01-15 | BTIG | Buy | reiterated | $84.38 | $100 | running to 2027-01-15 | +4.3% |
| 2026-01-08 | Cantor Fitzgerald | Overweight | maintained | $87.59 | $99 | replaced 2026-02-05, new $92 | -1.7% |
| 2026-01-08 | Wells Fargo | Overweight | maintained | $87.59 | $122 | replaced 2026-02-05, new $100 | -1.7% |
| 2026-01-06 | Wolfe Research | Outperform | maintained | $85.54 | $110 | running to 2027-01-06 | -6.3% |
| 2025-12-19 | Wedbush | Neutral | maintained | $79.31 | $78 | within 5% of price when set | -11.4% |
| 2025-12-08 | Morgan Stanley | Overweight | maintained | $92.57 | $110 | replaced 2026-02-05, new $100 | +0.6% |
| 2025-12-03 | Arete Research | Neutral → Buy | upgrade | $90.68 | $125 | running to 2026-12-03 | -9.1% |
| 2025-11-05 | UBS | Buy | maintained | $92.75 | $122 | replaced 2026-05-01, new $110 | — |
| 2025-11-05 | TD Cowen | Buy | maintained | $92.75 | $114 | replaced 2026-05-07, new $118 | — |
| 2025-11-05 | Barclays | Overweight | maintained | $92.75 | $107 | replaced 2026-08-06, new $106 | — |
| 2025-11-05 | Bernstein | Outperform | maintained | $92.75 | $115 | replaced 2026-08-06, new $95 | — |
| 2025-11-05 | Truist Securities | Buy | maintained | $92.75 | $110 | replaced 2026-05-07, new $112 | — |
| 2025-11-05 | Cantor Fitzgerald | Overweight | maintained | $92.75 | $108 | replaced 2026-01-08, new $99 | — |
| 2025-11-05 | Wells Fargo | Overweight | maintained | $92.75 | $120 | replaced 2026-01-08, new $122 | — |
| 2025-11-05 | Guggenheim | Buy | maintained | $92.75 | $135 | replaced 2026-02-18, new $125 | — |
| 2025-11-05 | BMO Capital | Outperform | maintained | $92.75 | $106 | running to 2026-11-05 | — |
| 2025-11-05 | DA Davidson | Buy | maintained | $92.75 | $108 | replaced 2026-02-23, new $105 | — |
| 2025-11-04 | BTIG | Buy | reiterated | $94.67 | $100 | running to 2026-11-04 | — |
| 2025-11-04 | Needham | Buy | reiterated | $94.67 | $109 | running to 2026-11-04 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.